Biotech Catalyst In June 2018


21-Jun-2018 18:50 PM



   Get ready biotech enthusiast investors, June will be the important month for the biotech sector with American Society of Clinical Oncology (#ASCO18) will be on June 1-5, 2018 in Chicago, Il. There will be hundreds of companies present abstract data and more. Here are the notable companies to watch:

  • Infinity Pharmaceuticals Inc (INFI) IPI-549. Abstract #3013, Monday, June 4
  • Loxo Oncology (LOXO)- details of LOXO-292 clinical data, abstract #102, Sunda,  June 3
  • CytomX Therapeutics Inc (CTMX) preliminary first-in-human data from PROCLAIM-CX-072
  • Adaptimmune Therapeutics PLC (ADAP) Myxoid/Round Cell Liposarcoma Data with NY-ESO and MAGE-A10 Study. Abstract #3005. Sat June 2.
  • Celgene Corp (CELG)- Abstract #8001; Friday, June 1. Abstract #7500; Sunday, June 3. CAR-T Abstract #8007, #7505, #7005, #8024
  • Incyte Corp (INCY) abstract #8005; Friday, June 1.
  • Clovis Oncology Inc (CLVS)-Abstract TPS4592-ATLAS: A phase 2, open-label study of rucaparib. Saturday, June 2

The Prescription Drug User Fee Act (PDUFA) catalyst in June:

  1. Valeant Pharmaceuticals International Inc (VRX)- June 18
  2. Achaogen Inc (AKAO) priority review June 25
  3. Merk & Co Inc (MRK)- June 25
  4. Pain Therapeutics Inc (PTIE) June 25
  5. GW Pharmaceuticals PLC (GWPH) June 27
  6. Array Biopharma Inc (ARRY) June 30

There are numerous data in June to mark the end of Q2 2018 biotech data. Here are the most notable company.

  • AceRx Pharmaceuticals (ACRX)
  • Axsome Therapeutics Inc (AXSM)
  • Corbus Pharmaceuticals Holdings Inc (CRBP) data present at EULAR June 13
  • CTi Biopharma Corp (CTIC)
  • Foamix Pharmaceuticals Ltd (FOMX)
  • Global Blood Therapeutics Inc (GBT)
  • Gemphire Therapeutics Inc (GEMP)
  • Heron Therapeutics Inc (HRTX)
  • Idera Pharmaceuticals Inc (IDRA)
  • Strongbridge Biopharma plc (SBBP)
  • Acceleron Pharma Inc (XLRN)

Here is the upcoming biotech data from our site

The #BiotechCalculator with 83% accuracy predicting data results.

What do you think of the list? let us know if there is a company you would like us to add to the list above. Thanks

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.